CDH1 and polycystic ovary syndrome: While there is increasing evidence suggesting that MUC-1 and E-cadherin are some of the biomarkers that are deregulated in the endometrium of PCOS patients, there are limited studies that associate weight and patients’ BMI with endometrial receptivity markers (17, 19, 25).